Skip to main content
. Author manuscript; available in PMC: 2022 Oct 12.
Published before final editing as: Oral Oncol. 2020 Aug 31;109:104687. doi: 10.1016/j.oraloncology.2020.104687

Table 1:

Demographic and Disease Characteristics of elderly patients with HPV+ and HPV− OPSCC

Variable HPV+ (n=62) HPV− (n=26) All Patients (n =88) p-valuea
Age, years 0.56
 Median (IQR) 74 (71–79) 73 (71–77) 73 (71–78)
Gender, n (%) 0.36
 Male 47 (76) 22 (85) 69 (78)
 Female 15 (24) 4 (15) 19 (22)
Race/Ethnicity, n (%) 0.007
 White 47 (76) 11 (42) 58 (66)
 Black 6 (10) 7 (27) 13 (15)
 Other 4 (6) 1 (4) 5 (6)
 Hispanic 5 (8) 7 (27) 12 (14)
Alcohol, n (%) 0.007
 Never/Moderate drinker 54 (87) 16 (62) 70 (80)
 Former Heavy drinker 3 (5) 7 (27) 10 (11)
 Current Heavy drinker 5 (8) 3 (12) 8 (9)
Smoking, n (%) 0.88
 Never 19 (31) 7 (27) 26 (30)
 Former 38 (61) 16 (62) 54 (61)
 Current 5 (8) 3 (12) 8 (9)
Smoking Pack Years, n (%) 0.99
 Never 19 (31) 7 (27) 26 (30)
 ≤10 pack years 11 (18) 5 (19) 16 (18)
 10–≤20 pack years 6 (10) 3 (12) 9 (10)
 >20 26 (42) 11 (42) 37 (42)
ECOG, n (%) 0.009
 0 31 (50) 6 (23) 37 (42)
 1 23 (37) 12 (46) 35 (40)
 2 8 (13) 5 (19) 14 (16)
 3 0 (0) 3 (12) 3 (3)
Charleston Comorbidity Index 0.66
 Median (IQR) 6(5–7) 6(5–7) 6 (5–7)
Stage (AJCC 8th edition), n (%) <.001
 I 23 (37) 0 (0) 23 (26)
 II 27 (44) 4 (15) 31 (35)
 III 12 (19) 3 (12) 15 (17)
 IVA 0 (0) 10 (38) 10 (11)
 IVB 0 (0) 9 (35) 9 (10)
Primary Site, n (%) 0.04b
 Base of tongue 35 (56) 17 (65) 52 (59)
 Palatine Tonsils 26 (42) 6 (23) 32 (36)
 Other 1 (2) 3 (12) 4 (5)
HPV subtype, n (%) n=42 <.001
 16 35 (83) N/A 35
 18 2 (5) 2
 33 1 (2) 1
 35 4 (10) 4
a;

p-values relate to HPV+ versus HPV−

b;

p-value=0.16 when other is not included in statistical analysis